Travera Inc. Press releases
Jul 14, 2025
Travera Inc. Announces CLIA Approval of First-of-Its-Kind Blood Test to Assess Personalized Functional Response to Cancer Immunotherapy Medford, MA — July 14, 2025 — Travera, a leader in functional precision oncology, today announced that its novel...